Back to top
more

HCA Healthcare (HCA)

(Delayed Data from NYSE)

$341.26 USD

341.26
1,176,514

+3.82 (1.13%)

Updated Jun 10, 2024 04:00 PM ET

After-Market: $341.34 +0.08 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 13% (31 out of 248)

Industry: Medical - Hospital

Better trading starts here.

Zacks News

Here's Why HCA Healthcare (HCA) Fell More Than Broader Market

HCA Healthcare (HCA) concluded the recent trading session at $279.33, signifying a -0.77% move from its prior day's close.

HCA Healthcare (HCA) Advances While Market Declines: Some Information for Investors

In the latest trading session, HCA Healthcare (HCA) closed at $275.32, marking a +1.71% move from the previous day.

Reasons to Retain HCA Healthcare (HCA) Stock in Your Portfolio

HCA Healthcare's (HCA) improving top line, acquisition initiatives and a robust growth outlook poise the company well for growth.

HCA Healthcare (HCA) Rises Higher Than Market: Key Facts

In the most recent trading session, HCA Healthcare (HCA) closed at $269.18, indicating a +0.75% shift from the previous trading day.

HCA Healthcare, Inc. (HCA) Is a Trending Stock: Facts to Know Before Betting on It

HCA (HCA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Wall Street Bulls Look Optimistic About HCA (HCA): Should You Buy?

The average brokerage recommendation (ABR) for HCA (HCA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems

HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems are part of the Zacks Industry Outlook article.

Kaibalya Pravo Dey headshot

5 Hospital Stocks to Watch Amid Promising Industry Trends

Rising patient volumes and technological advancements for the Zacks Medical-Hospital industry players are major positives. HCA, UHS, THC, ACHC and CYH are poised to gain from improving operating efficiency.

HCA Healthcare (HCA) Beats Stock Market Upswing: What Investors Need to Know

HCA Healthcare (HCA) closed the most recent trading day at $262.02, moving +1.74% from the previous trading session.

HCA Healthcare's (HCA) Houston Affiliate Acquires 11 EDs

The deal helps HCA Healthcare (HCA) boost its freestanding EDs in the Houston region to 26, supplementing its existing hospital-based emergency rooms.

HCA Healthcare (HCA) Increases Despite Market Slip: Here's What You Need to Know

HCA Healthcare (HCA) concluded the recent trading session at $257.14, signifying a +1.89% move from its prior day's close.

Investors Heavily Search HCA Healthcare, Inc. (HCA): Here is What You Need to Know

HCA (HCA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Wall Street Analysts Think HCA (HCA) Is a Good Investment: Is It?

The average brokerage recommendation (ABR) for HCA (HCA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Universal Health Services (UHS) Up 11.4% Since Last Earnings Report: Can It Continue?

Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Is HCA (HCA) Up 12.3% Since Last Earnings Report?

HCA (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

HCA Healthcare (HCA) Unveils Ambitious 5-Year Growth Targets

Over the five-year horizon, HCA Healthcare (HCA) anticipates substantial 8-12% annual growth in earnings per share.

Sanghamitra Saha headshot

3 Sector ETFs & Stocks to Gain Despite Soft Jobs Data

The U.S. economy added 150,000 jobs in October 2023, below market forecasts of 180,000.

Here is What to Know Beyond Why HCA Healthcare, Inc. (HCA) is a Trending Stock

HCA (HCA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

The Zacks Analyst Blog Highlights Costco Wholesale, Pfizer, IBM, NextEra Energy and HCA Healthcare

Costco Wholesale, Pfizer, IBM, NextEra Energy and HCA Healthcare are part of the Zacks top Analyst Blog.

Mark Vickery headshot

Top Research Reports for Costco, Pfizer & IBM

Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corp. (COST), Pfizer Inc. (PFE) and IBM Corp. (IBM).

Community Health (CYH) Stock Down 1.7% Since Q3 Earnings Release

Community Health (CYH) expects net operating revenues in the range of $12,400-$12,500 million for 2023.

HCA Healthcare's (HCA) Q3 Earnings Miss on High Expense Level

HCA Healthcare's (HCA) Q3 results were hurt by an increase in salaries and benefits expenses. Management presently estimates 2023 EPS to be within $17.80-$18.50, compared with the prior-view of $17.70-$18.90 per share.

HCA (HCA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for HCA (HCA) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

HCA Healthcare (HCA) Lags Q3 Earnings Estimates

HCA (HCA) delivered earnings and revenue surprises of -1.51% and 2.80%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Mayur Thaker headshot

Yield Curve Rapidly Steepens in First Test of Bear Steepening In 40 Years

Risks continue to rise as the key equity index loses medium term moving averages